MedinCell SA (MEB) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Ivermectin Tablets | Covid-19 | Phase II | Completed | A Study to Evaluate the Efficacy and Safety of Ivermectin in COVID-19 Prevention | Mar 28, 2022 | ― |
| Ivermectin | COVID19 | Phase I | Completed | Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19 | Oct 26, 2020 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Ivermectin Tablets | Phase II | Covid-19 | Completed | A Study to Evaluate the Efficacy and Safety of Ivermectin in COVID-19 Prevention | Mar 28, 2022 | ― |
| Ivermectin | Phase I | COVID19 | Completed | Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19 | Oct 26, 2020 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does MedinCell SA (DE:MEB) have in its pipeline
MedinCell SA DE:MEB is currently developing the following drugs: Ivermectin Tablets, Ivermectin. These drug candidates are in various stages of clinical development as the company works toward FDA approval.